Skin Diseases, Vesiculobullous D012872

Diseases [C] » Skin and Connective Tissue Diseases [C17] » Skin Diseases » Skin Diseases, Vesiculobullous

Description

Skin diseases characterized by local or general distributions of blisters. They are classified according to the site and mode of blister formation. Lesions can appear spontaneously or be precipitated by infection, trauma, or sunlight. Etiologies include immunologic and genetic factors. (From Scientific American Medicine, 1990)   MeSH

Subtype Terms (13)

Acantholysis
 

Blister
4 drugs (3 approved, 1 experimental)

Dermatitis Herpetiformis
9 drugs (7 approved, 2 experimental)

Eczema, Dyshidrotic
1 experimental drug

Epidermolysis Bullosa
47 drugs (19 approved, 28 experimental)

Erythema Multiforme
3 approved drugs

Hydroa Vacciniforme
 

Linear IgA Bullous Dermatosis
3 drugs (1 approved, 2 experimental)

Pemphigoid, Benign Mucous Membrane
8 drugs (6 approved, 2 experimental)

Pemphigoid, Bullous
25 drugs (18 approved, 7 experimental)

Pemphigoid Gestationis
1 experimental drug

Pemphigus
34 drugs (20 approved, 14 experimental)

Pemphigus, Benign Familial
1 approved drug


Phase 4 Indicated Drugs (1)


Organization Involved with Phase 1 Indications (1)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.